Bill > H1109

This bill creates Section 465.41 of the Florida Statutes to address the distribution of compounded human drug products. The key provisions are: 1) The legislature intends to enhance communication and maximize federal and state resources for oversight of compounded drugs produced by traditional pharmacies, and to enact an information sharing agreement with the U.S. Food and Drug Administration (FDA) to monitor such drug products. 2) The State Surgeon General is required to sign and become a party to the FDA's Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products on behalf of the Florida Department of Health. 3) Licensed persons who ship compounded human drug products interstate must annually report certain information required by the Memorandum of Understanding to the National Association of Boards of Pharmacy Information-Sharing Network. The bill aims to improve oversight and monitoring of compounded drugs produced and distributed across state lines.

Health and Social Services

https://www.flsenate.gov/Session/Bill/2022/1109